Organ-on-Chip Market

Organ-on-Chip Market Research, 2030

The global organ-on-chip market was valued at $103.44 million in 2020, and is projected to reach $1.6 billion by 2030, growing at a CAGR of 31.1% from 2021 to 2030.Organ-on-chip is a type of artificial organ that simulates human organs. It is a multichannel 3D micro-fluidic cell culture device, which stimulates activities, mechanisms, and physiological responses of organs. The combination of labs-on-chips (LOCs) and cell biology has allowed researchers to examine human physiology in an organ-specific environment, resulting in the development of a new model of in vitro multicellular human organisms. This chip develops a narrow channel for the blood and air flow in organs including, lung, gut, brain, liver, and heart. These devices are developed on a microchip that contains continuously perfused chambers colonized by living cells arranged to stimulate tissues and organ level physiology. Organ-on-chip is a device that is used to nurture internal organs with the help of silicone.

COVID-19 outbreak is anticipated to have a positive impact on the organ-on-chip market. A huge number of clinics and hospitals across the globe were restructured to increase the hospital capacity for patients diagnosed with COVID-19. Nonessential procedures took a potential backlog, owing to rapid rise in COVID-19 cases. The lockdown led to disruption of manufacturing and transportation of healthcare essentials. However, during the COVID-19 pandemic, organ-on-chip emerged as a promising technology for the development of drugs and vaccines, which were under research and clinical trials for the infection. Thus, it had a significantly positive impact during the pandemic.

Organ-on-chip is a potentially game changing technology that combines tissue engineering and microfluidics. These technologies are predicted to provide effective answers to long standing issues in medication discovery and individualized disease treatment. It plays a major role in drug development studies, thus boosting the organ-on-chip industry.

The global organ-on-chip market is driven by increase in its applications in the healthcare sector, rise in demand for drug screening, and surge in demand for lung-based organ culture & kidney applications. Surge in alternative of animal testing by research activities on organ-on-chip devices for new drug development is expected to majorly boost the organ-on-chip market in upcoming years.

In addition, surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the global organ-on-chip market. Real-time imaging, in vitro analysis of biochemical, and genetic & metabolic activities of living cells in a functional tissue are some of the applications of organ-on-chip devices in the healthcare industry. Advancements in cell biology, microfabrication, and microfluidics have led to increase in adoption of organ-on-chips, thereby fueling the organ-on-chip market growth.

Increase in demand for organ-on-chips in drug screening, rise in demand for lung- & kidney-based organ culture devices is expected to boost the organ-on-chip market size. Moreover, the shortage of donor organs and availability of laboratory-engineered functional organs are expected to be a major advantage to cater to the growing demands of organs transplantation. However, high cost of the organ chip device and the development of organ-on-chip (OOC) technology is still in its nascent stage, and is expected to restrain growth of the market. Conversely, considerable rise in healthcare expenditure across the globe has led to the increase of organ-on-chip market size. Emerging economies possess high potential for organ-on-chip market. Increase in number of chronic diseases, high requirement for organ transplantation, and surge in animal testing for drug discovery are expected to drive demand for these products over the next few years

Organ-on-chip Market segmentation

The organ-on-chip market analysis is segmented on the basis of type and region. Depending on type, it is classified into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lung-on-chip.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East and Africa).

Segment Review

Depending on product, the lung-on-chip segment of the organ-on-chip industry dominated the market in 2020, and is expected to remain dominant during the forecast period, owing to lower lung transplantations, which has led to development of laboratory engineered chips to mimic their functions and for drug screening for respiratory disorders.

North America exhibited the global organ-on-chip market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in prevalence of technologically advanced models, presence of key players, and rise in R & D activities for drug discovery and development. However, Asia-Pacific is anticipated to witness notable organ-on-chip market opportunity, owing to increase in R&D activities, increase in healthcare investment, and various strategies among key players. Moreover, India and China are expected to grow at high CAGR in the Asia-Pacific organ-on-chip market forecast.  

The key players operating in the global organ-on-chip market are AxoSim Technologies LLC., BICO Group AB(Visikol), CN Bio Innovations Limited, Elveflow, Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc., and Tara Biosystems.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the organ-on-chip market analysis from 2020 to 2030 to identify the prevailing organ-on-chip market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the organ-on-chip market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global organ-on-chip market trends, key players, market segments, application areas, and market growth strategies.

 Organ-on-Chip Market Report Highlights